Fresenius Medical Care (FMS) PT Lowered to $36 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street rises on revived AI momentum as earnings season picks up
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts FMS Hot Sheet
Price: $22.54 -0.92%
Rating Summary:
7 Buy, 12 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 17 | New: 17
Rating Summary:
7 Buy, 12 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 17 | New: 17
Join SI Premium – FREE
RBC Capital analyst Frank Morgan lowered the price target on Fresenius Medical Care (NYSE: FMS) to $36.00 (from $43.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- US Seeks More Competition In Kidney Treatment Market - Axios
- Canaccord Downgrades Botanix Pharmaceuticals Ltd (BOT:AU) to Hold
- Ballard Power Systems (BLDP) PT Lowered to $1.68 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
